Drug intelligence / Profile preview

ammonium lactate + urea

Development stage: Unknown
Lead developer: Bristol Myers Squibb
Modality: Small Molecules
Administration: Topical

Overview

Ammonium lactate + urea is a topical combination medication used to treat rough, scaly skin conditions such as eczema, psoriasis, xerosis (dry skin), and ichthyosis vulgaris. Ammonium lactate acts as an alpha-hydroxy acid moisturizer that increases skin hydration by promoting water retention in the stratum corneum. Urea is a keratolytic agent that loosens thick or scaly skin cells, facilitating their shedding and softening cracked or callused areas. This combination helps restore moisture balance and improve the texture of dry or hyperkeratotic skin[1][3][6].

Brand names: UltralyticUltralytic 2Ultralytic2Ultralytic-2Carb-O-Lac HPCarb-O-Lac5Carb-O-Lac-5Carb-O-Lac 5Kerasal Ultra 20
Other names: ammonium lactate and urea topical

Beyond the preview

Go deeper on ammonium lactate + urea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ammonium lactate + urea.

Explore the full profile